Evaluation of the effectiveness of physical therapy for people with infantile cerebral palsy using the KRISAF robot assistant

ISRCTN ISRCTN10054755
DOI https://doi.org/10.1186/ISRCTN10054755
Submission date
10/02/2025
Registration date
26/02/2025
Last edited
06/06/2025
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
This is an evaluation of the effectiveness of physical therapy for people with cerebral palsy using the KRISAF assistant robot. Infantile cerebral palsy (CP) is a condition in which a child's muscles and movements are disrupted. This makes it difficult for children to walk, run, stand, and perform other movements. They use physical therapy to improve their condition but this requires special devices. One of these devices is the KRISAF robot assistant. KRISAF helps children perform exercises that they would not be able to do on their own. It supports their body as they move and makes sure they do everything right. To assess the effectiveness of this method, a special scale is used. This helps measure how much the child's motor skills have improved after using a device KRISAF. The higher the score on the scale, the better the child copes with the child's movements. The results show that KRISAF classes can help children with cerebral palsy improve their motor skills. A pilot study was conducted in the medical center of the city of Yekaterinburg, which showed the effectiveness of using the robotic complex. It was decided to repeat this study in several health centers. The aim of the study is to prove the effectiveness of rehabilitation using a robotic complex, which can make children's lives more comfortable, active and independent.

Who can participate?
Children 6-12 years of age with cerebral palsy

What does the study involve?
Participants are randomly allocated to one of two groups, one of which will receive standard treatment and the other standard treatment
including classes at the Krisaf complex.

What are the possible benefits and risks of participating?
The main advantage of the study is the new technology implemented in the Krisaf robotics complex. This complex helps in maintaining and restoring the range of motion in the joints, normalizing muscle tone and restoring proper execution of body movements. The technology has minimal risks, such as discomfort during sports. If you feel uncomfortable, you can interrupt the session.

Where is the study run from?
Aspect Medical (Russia)

When is the study starting and how long is it expected to run for?
October 2024 to October 2025

Who is funding the study?
Aspect Medical (Russia)

Who is the main contact?
Tatyana S. Poltavskaya, tysayny@yandex.ru

Contact information

Prof Vera Zmanovskaya
Public, Scientific, Principal Investigator

Tumen state
Tumen
625000
Russian Federation

Phone +7 (0)89193740305
Email tysayny@yandex.ru
Mrs Tatiana Poltavskaya
Public, Scientific

Ekaterinburg
Ekaterinburg
620146
Russian Federation

ORCiD logoORCID ID 0000-0003-0139-3726
Phone +7 (0)89193740305
Email tysayny@yandex.ru

Study information

Study designRandomized controlled interventional trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeSafety, Efficacy
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleEvaluation of the effectiveness of locomotor therapy in a supportless state using the robot assistive complex KRISAF in patients with cerebral palsy based on the GMFM 66 scale
Study acronymKRISAF
Study objectivesRandomized controlled multicenter study of the effectiveness and safety of a new method of rehabilitation therapy for motor disorders in patients with cerebral palsy with spastic diplegia using a robotic complex for locomotor therapy in an unsupported state
Ethics approval(s)

Approved 23/12/2024, Committee on Ethics and Deontology of the healthcare institution "Minsk city center for medical rehabilitation of children with Neuropsychiatric diseases" (St Uralskaya 5, Minsk, 220004, Belarus; +375 (17)239-59-12; firststep@cu.bc.by), ref: 2

Health condition(s) or problem(s) studiedCerebral palsy
InterventionParticipants diagnosed with CP with spastic diplegia classified as Gross Motor Function Classification Scale (GMFCS) Levels I-V will be recruited and divided equally into two groups (G1 and G2). Randomization will be performed using the envelope method. The first group (G1) will receive rehabilitation at the complex for locomotor therapy "Krisaf", 8-10 sessions including swimming, jumping, crawling, walking for 5-7 minutes, and jumping-assisted mode for 3-5 minutes. There are only 10 sessions, an average of 30 minutes each. Standard methods of rehabilitation.

Control group (G2): Standard rehabilitation methods. Standard complex of rehabilitation including kinesiotherapy and mechanotherapy.
Intervention typeDevice
Pharmaceutical study type(s)Not Applicable
PhasePhase IV
Drug / device / biological / vaccine name(s)Robot assistive complex Krisaf
Primary outcome measureFunctional state and motor function measured using the Tardieu scale and Gross Motor Function Measure 66 (GMFM-66) on the 1st day and the 10th day of classes
Secondary outcome measuresNeurological examination on the 1st day and the 10th day of classes
Overall study start date22/10/2024
Completion date22/10/2025

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit6 Years
Upper age limit12 Years
SexBoth
Target number of participants120
Total final enrolment120
Key inclusion criteria1. Patients with a verified diagnosis of cerebral palsy (spastic forms of cerebral palsy, diplegia and quadriplegia)
2. Aged 6-12 years
3. GMFCS level 1-4
4. The presence of communicative contact with the child (Communication Function Classification System [CFCS] 1-3)
5. Voluntary consent to conduct the study
Key exclusion criteria1. Acute inflammatory diseases
2. Somatic pathology in the stage of decompensation
3. Severe orthopedic disorders (hip dislocation)
4. Lack of communication contact with the child
5. Epilepsy
6. Lack of voluntary consent
Date of first enrolment06/01/2025
Date of final enrolment06/04/2025

Locations

Countries of recruitment

  • Belarus
  • Russian Federation

Study participating centres

State Institution "Minsk City Center for Social Services for Families and Children"
St Uralskaya 5
Minsk
220004
Belarus
Multiprofile Clinical Medical Center "Bonum"
St Bardina 4a
Ekaterinburg
620000
Russian Federation
State Educational Institution TO DLRC "Nadezhda"
Tumen
223054
Russian Federation

Sponsor information

Aspect Medical
Industry

Ekaterinburg st Uralskaya 86\1
Ekaterinburg
620041
Russian Federation

Phone +7 (0)8 (343) 363-03-12
Email mail@aspectmedical.eu

Funders

Funder type

Industry

Aspect Medical Systems
Private sector organisation / For-profit companies (industry)
Location
Ireland

Results and Publications

Intention to publish date05/05/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryPublished as a supplement to the results publication
Publication and dissemination planPublishing results in a peer-reviewed journal
IPD sharing planThe dataset generated and analysed during the current will be published as a supplement to the results publication

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Other files CRF in Russan 06/06/2025 No No

Additional files

ISRCTN10054755 CRF in Russian клинический протокол.pdf
CRF in Russan

Editorial Notes

06/06/2025: A CRF was uploaded as an additional file.
10/02/2025: Study's existence confirmed by the Committee on Ethics and Deontology of the healthcare institution "Minsk city center for medical rehabilitation of children with neuropsychiatric diseases".